| pubmed-article:15972549 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15972549 | lifeskim:mentions | umls-concept:C0018483 | lld:lifeskim |
| pubmed-article:15972549 | lifeskim:mentions | umls-concept:C0023820 | lld:lifeskim |
| pubmed-article:15972549 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:15972549 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
| pubmed-article:15972549 | lifeskim:mentions | umls-concept:C0596988 | lld:lifeskim |
| pubmed-article:15972549 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:15972549 | pubmed:dateCreated | 2005-6-23 | lld:pubmed |
| pubmed-article:15972549 | pubmed:abstractText | The Haemophilus influenzae P4 lipoprotein (hel) is a potential component of a nontypeable H. influenzae otitis media vaccine. Since P4 is known to be an enzyme, nonenzymatically active forms of recombinant P4 are required. After site-directed mutagenesis of the hel gene, three of the mutated proteins were shown to be vaccine candidates. | lld:pubmed |
| pubmed-article:15972549 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15972549 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15972549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15972549 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15972549 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:15972549 | pubmed:issn | 0019-9567 | lld:pubmed |
| pubmed-article:15972549 | pubmed:author | pubmed-author:SmithArnold... | lld:pubmed |
| pubmed-article:15972549 | pubmed:author | pubmed-author:GreenBruce... | lld:pubmed |
| pubmed-article:15972549 | pubmed:author | pubmed-author:ReillyThomas... | lld:pubmed |
| pubmed-article:15972549 | pubmed:author | pubmed-author:ZlotnickGary... | lld:pubmed |
| pubmed-article:15972549 | pubmed:author | pubmed-author:BaranyiElizab... | lld:pubmed |
| pubmed-article:15972549 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15972549 | pubmed:volume | 73 | lld:pubmed |
| pubmed-article:15972549 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15972549 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15972549 | pubmed:pagination | 4454-7 | lld:pubmed |
| pubmed-article:15972549 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:15972549 | pubmed:meshHeading | pubmed-meshheading:15972549... | lld:pubmed |
| pubmed-article:15972549 | pubmed:meshHeading | pubmed-meshheading:15972549... | lld:pubmed |
| pubmed-article:15972549 | pubmed:meshHeading | pubmed-meshheading:15972549... | lld:pubmed |
| pubmed-article:15972549 | pubmed:meshHeading | pubmed-meshheading:15972549... | lld:pubmed |
| pubmed-article:15972549 | pubmed:meshHeading | pubmed-meshheading:15972549... | lld:pubmed |
| pubmed-article:15972549 | pubmed:meshHeading | pubmed-meshheading:15972549... | lld:pubmed |
| pubmed-article:15972549 | pubmed:meshHeading | pubmed-meshheading:15972549... | lld:pubmed |
| pubmed-article:15972549 | pubmed:meshHeading | pubmed-meshheading:15972549... | lld:pubmed |
| pubmed-article:15972549 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15972549 | pubmed:articleTitle | Certain site-directed, nonenzymatically active mutants of the Haemophilus influenzae P4 lipoprotein are able to elicit bactericidal antibodies. | lld:pubmed |
| pubmed-article:15972549 | pubmed:affiliation | Wyeth Vaccines Discovery Research, Bldg. 205/3104, 401 N. Middletown Road, Pearl River, New York 10965, USA. greenba@wyeth.com | lld:pubmed |
| pubmed-article:15972549 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15972549 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15972549 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15972549 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15972549 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15972549 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15972549 | lld:pubmed |
